79 related articles for article (PubMed ID: 9157976)
1. Application of telomerase assay for the screening of cervical lesions.
Kyo S; Takakura M; Ishikawa H; Sasagawa T; Satake S; Tateno M; Inoue M
Cancer Res; 1997 May; 57(10):1863-7. PubMed ID: 9157976
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Nagai N; Oshita T; Murakami J; Ohama K
Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
[TBL] [Abstract][Full Text] [Related]
3. Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma.
Jarboe EA; Liaw KL; Thompson LC; Heinz DE; Baker PL; McGregor JA; Dunn T; Woods JE; Shroyer KR
Oncogene; 2002 Jan; 21(4):664-73. PubMed ID: 11850794
[TBL] [Abstract][Full Text] [Related]
4. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Takakura M; Kyo S; Kanaya T; Tanaka M; Inoue M
Cancer Res; 1998 Apr; 58(7):1558-61. PubMed ID: 9537264
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
Naritoku WY; Datar RH; Li P; Groshen SL; Taylor CR; Imam SA
Cancer; 1999 Aug; 87(4):210-5. PubMed ID: 10455209
[TBL] [Abstract][Full Text] [Related]
6. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
7. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
8. High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
Wang PH; Chen GD; Chang H; Yang SF; Han CP; Lin LY; Ko JL
Reprod Sci; 2007 May; 14(4):338-48. PubMed ID: 17644806
[TBL] [Abstract][Full Text] [Related]
9. Telomerase in (pre)neoplastic cervical disease.
Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J
J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675
[TBL] [Abstract][Full Text] [Related]
12. [Telomerase activity in the uterine cervix and the uterine body].
Nakayama H; Kato H; Okajima H; Yasumoto S
Nihon Rinsho; 1998 May; 56(5):1305-9. PubMed ID: 9613142
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
14. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions.
Kyo S; Takakura M; Tanaka M; Kanaya T; Inoue M
Int J Cancer; 1998 Feb; 79(1):66-70. PubMed ID: 9495361
[TBL] [Abstract][Full Text] [Related]
16. Telomerase--a potential molecular marker of lung and cervical cancer.
Sen S; Reddy VG; Guleria R; Jain SK; Kapila K; Singh N
Clin Chem Lab Med; 2002 Oct; 40(10):994-1001. PubMed ID: 12476937
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.
Wisman GB; Hollema H; de Jong S; ter Schegget J; Tjong-A-Hung SP; Ruiters MH; Krans M; de Vries EG; van der Zee AG
J Clin Oncol; 1998 Jun; 16(6):2238-45. PubMed ID: 9626226
[TBL] [Abstract][Full Text] [Related]
18. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix.
Shroyer KR; Thompson LC; Enomoto T; Eskens JL; Shroyer AL; McGregor JA
Am J Clin Pathol; 1998 Feb; 109(2):153-62. PubMed ID: 9583886
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer.
Zhang DK; Ngan HY; Cheng RY; Cheung AN; Liu SS; Tsao SW
Eur J Cancer; 1999 Jan; 35(1):154-60. PubMed ID: 10211104
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in gynecological tumors.
Kyo S; Kanaya T; Ishikawa H; Ueno H; Inoue M
Clin Cancer Res; 1996 Dec; 2(12):2023-8. PubMed ID: 9816162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
